# Celanese Corporation (CE) fundamentals

Data as of 2026-11-04. NYSE, United States. Sector: Basic Materials / Chemicals. Price $50.36, market value $5.5 billion.

## Valuation
- **P/E (trailing): 20.4×** (5-yr avg 7.8×, 3-yr avg 8.5×). Celanese Corporation trades at 20.4× trailing earnings, well above its own five-year average of 7.8×: investors are paying up relative to the company's past. The Basic Materials median in the September 2026 study was 19.0×. Forward P/E is 8.3×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.34**. A PEG of 0.34 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 0.6×**. Each dollar of revenue is priced at 0.6×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 1.3×**. The shares trade at 1.3× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 137.2×**. Enterprise value is 137.2× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: 12.8%** (5-yr avg 10.4%). Free cash flow equals 12.8% of the market value, above its five-year average of 10.4%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 4.9%**. The inverse of the P/E: 4.9% of the price is earned each year.

## Profitability
- **Gross margin: 20.9%**. Celanese Corporation keeps 20.9% of revenue after the direct cost of what it sells, a thin margin typical of retail, distribution and commodity businesses.
- **Operating margin: -7.1%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -12.2%**. The company reported a net loss over the last twelve months.
- **Return on equity: -28.8%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -3.1%**. Return on all capital, debt included, is -3.1%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -5.4%**. Each dollar of assets produces -5.4% of profit.

## Growth
- **Revenue growth (1 yr): -7.1%** (3-yr -0.4%/yr, 5-yr 11.0%/yr). Revenue fell 7.1% over the last year, against 11.0% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 24.6%**. Earnings per share rose 24.6%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): -14.3%/yr**. Free cash flow has compounded at -14.3% a year over three years.

## Financial health
- **Debt to equity: 3.41**. Debt is 3.41 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Current ratio: 1.55** (quick 1.55). Current assets cover the next year's liabilities 1.55 times.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 0.24%** ($0.12 per share, trailing). Celanese Corporation yields 0.24%, a modest yield more typical of a growth-oriented payer.
- **Dividend growth (5 yr): -45.4%/yr** (1-yr -95.7%). The dividend has not grown over five years.

## Analyst view
- **Analyst consensus: buy** (18 analysts). 18 analysts cover Celanese Corporation; the consensus is buy, with an average price target of $61.17 (+21% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 24.9%** (YTD 13.6%, 3-mo 9.2%). The shares are up 24.9% over twelve months including dividends.
- **From 52-week high: -28.8%** (43.4% above the low). Trading 29% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 55**. An RSI of 55 is neutral.
- **Beta (1 yr): 0.53** (volatility 51%). Beta of 0.53 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=CE · Page: https://foliofundamentals.com/stocks/ce

Not investment advice.